Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 3:32 pm Purchase | 13G | CAN-FITE BIOPHARMA LTD SPONSOR CANF | ARMISTICE CAPITAL LLC | 653,946 9.99% | 653,946 (New Position) | View |
| 2022-02-14 3:23 pm Unchanged | 13G | CAN-FITE BIOPHARMA LTD SPONSOR CANF | CVI Investments Inc. | 23,161,650 3.7% | 0 (Unchanged) | View |
| 2022-02-11 06:52 am Purchase | 13G | CAN-FITE BIOPHARMA LTD SPONSOR CANF | INTRACOASTAL CAPITAL LLC | 39,495,437 4.99% | 6,583,787 (+20.00%) | View |
| 2022-02-04 3:59 pm Unchanged | 13G | CAN-FITE BIOPHARMA LTD SPONSOR CANF | Hudson Bay Capital Management LP | 24,384,150 4.08% | 0 (Unchanged) | View |
| 2021-02-16 09:54 am Sale | 13G | CAN-FITE BIOPHARMA LTD SPONSOR CANF | CVI Investments Inc. | 23,161,650 5% | -6,106,650 (-20.86%) | View |
| 2021-02-08 6:04 pm Purchase | 13G | CAN-FITE BIOPHARMA LTD SPONSOR CANF | Hudson Bay Capital Management LP | 24,384,150 5.01% | 14,634,150 (+150.09%) | View |
| 2021-01-29 06:51 am Purchase | 13G | CAN-FITE BIOPHARMA LTD SPONSOR CANF | INTRACOASTAL CAPITAL LLC | 32,911,650 6.6% | 32,547,547 (+8939.10%) | View |
| 2020-06-19 4:23 pm Purchase | 13G | CAN-FITE BIOPHARMA LTD SPONSOR CANF | ARMISTICE CAPITAL LLC | 719,980 4.99% | 329,260 (+84.27%) | View |
| 2020-06-19 06:02 am Purchase | 13G | CAN-FITE BIOPHARMA LTD SPONSOR CANF | CVI Investments Inc. | 29,268,300 7.1% | 29,268,300 (New Position) | View |
| 2020-02-20 4:24 pm Purchase | 13G | CAN-FITE BIOPHARMA LTD SPONSOR CANF | ARMISTICE CAPITAL LLC | 390,720 4.99% | 390,720 (New Position) | View |
| 2020-02-14 5:11 pm Sale | 13G | CAN-FITE BIOPHARMA LTD SPONSOR CANF | Anson Funds Management LP | 721,644 0.6% | -3,754,548 (-83.88%) | View |
| 2020-02-11 06:13 am Sale | 13G | CAN-FITE BIOPHARMA LTD SPONSOR CANF | INTRACOASTAL CAPITAL LLC | 364,103 8.3% | -5,226,955 (-93.49%) | View |
| 2020-01-31 3:34 pm Purchase | 13G | CAN-FITE BIOPHARMA LTD SPONSOR CANF | Hudson Bay Capital Management LP | 9,750,000 7.53% | 9,750,000 (New Position) | View |
| 2020-01-08 5:21 pm Sale | 13G | CAN-FITE BIOPHARMA LTD SPONSOR CANF | SABBY MANAGEMENT LLC | 5,970,834 11% | -3,787,026 (-38.81%) | View |
| 2019-10-24 10:49 am Sale | 13D | CAN-FITE BIOPHARMA LTD SPONSOR CANF | Capital Point Ltd. | 5,509,260 4.6% | -7,334,760 (-57.11%) | View |
| 2019-10-17 5:30 pm Unchanged | 13D | CAN-FITE BIOPHARMA LTD SPONSOR CANF | Capital Point Ltd. | 12,844,020 10.73% | 0 (Unchanged) | View |
| 2019-09-11 4:15 pm Unchanged | 13D | CAN-FITE BIOPHARMA LTD SPONSOR CANF | Capital Point Ltd. | 12,844,020 12.88% | 0 (Unchanged) | View |
| 2019-08-08 10:54 am Unchanged | 13D | CAN-FITE BIOPHARMA LTD SPONSOR CANF | Capital Point Ltd. | 12,844,020 12.88% | 0 (Unchanged) | View |
| 2019-07-10 10:14 am Purchase | 13D | CAN-FITE BIOPHARMA LTD SPONSOR CANF | Capital Point Ltd. | 12,844,020 12.88% | 873,000 (+7.29%) | View |
| 2019-06-14 08:01 am Unchanged | 13D | CAN-FITE BIOPHARMA LTD SPONSOR CANF | Capital Point Ltd. | 11,971,020 12% | 0 (Unchanged) | View |